Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ABC294640 in Treating Patients With Advanced Solid Tumors (ABC-101)

This study has been completed.
Sponsor:
Collaborators:
Apogee Biotechnology Corporation
Medical University of South Carolina
FDA Office of Orphan Products Development
National Cancer Institute (NCI)
Information provided by (Responsible Party):
RedHill Biopharma Limited
ClinicalTrials.gov Identifier:
NCT01488513
First received: September 29, 2011
Last updated: August 19, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)